Cibc World Market Inc. Grows Stock Holdings in HCA Healthcare, Inc. $HCA

Cibc World Market Inc. lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 21.2% during the 3rd quarter, Holdings Channel.com reports. The firm owned 36,174 shares of the company’s stock after acquiring an additional 6,322 shares during the period. Cibc World Market Inc.’s holdings in HCA Healthcare were worth $15,417,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Clearstead Trust LLC boosted its position in shares of HCA Healthcare by 311.8% in the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after acquiring an additional 53 shares during the last quarter. Harbor Capital Advisors Inc. raised its stake in HCA Healthcare by 82.9% during the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock worth $32,000 after purchasing an additional 34 shares during the period. Twin Peaks Wealth Advisors LLC purchased a new stake in shares of HCA Healthcare during the 2nd quarter valued at $40,000. Compound Global Advisors LLC acquired a new position in HCA Healthcare in the third quarter valued at $44,000. Finally, True Wealth Design LLC increased its stake in HCA Healthcare by 179.5% during the third quarter. True Wealth Design LLC now owns 109 shares of the company’s stock worth $47,000 after acquiring an additional 70 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Zacks Research raised FY-2026 EPS to $29.31 (from $28.47) and lifted multiple quarterly and multi‑year estimates (FY2027 to $33.44, FY2028 to $37.67), aligning analyst expectations with HCA’s FY2026 guidance and suggesting stronger forward profitability. Zacks remains at a “Hold” rating, but the higher estimates support valuation and earnings momentum. Zacks estimate changes (MarketBeat)
• Neutral Sentiment: HCA’s StoneSprings Hospital Center is planning to convert a Chantilly deli site into a freestanding emergency room — a local expansion that could modestly increase patient volumes and admissions in that market over time. HCA StoneSprings freestanding ER
• Neutral Sentiment: HCA-related ASC real estate was sold, a move that can free capital or change lease/operating dynamics for ambulatory surgery centers; the net effect depends on deal terms and use of proceeds. HCA ASC real estate sold
• Neutral Sentiment: Executive moves: a former HCA Florida executive joined Memorial Health as COO and an HCA veteran was named COO at Memorial Health in Georgia — routine industry leadership turnover that may have limited near‑term impact on HCA’s financials but is notable for regional competitive dynamics and management talent flow. Former HCA exec joins Memorial Health (MSN) HCA veteran named COO (Becker’s)

Analyst Ratings Changes

HCA has been the subject of a number of research reports. Truist Financial boosted their target price on HCA Healthcare from $520.00 to $546.00 and gave the stock a “buy” rating in a report on Wednesday, January 28th. UBS Group increased their price objective on shares of HCA Healthcare from $525.00 to $598.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Wall Street Zen raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 25th. Bank of America boosted their price objective on HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a research note on Monday, October 27th. Finally, Robert W. Baird raised their target price on HCA Healthcare from $423.00 to $450.00 and gave the company a “neutral” rating in a report on Thursday, December 11th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $523.27.

HCA Healthcare Trading Up 0.7%

HCA Healthcare stock opened at $535.24 on Friday. The stock has a market cap of $119.69 billion, a P/E ratio of 18.86, a price-to-earnings-growth ratio of 1.63 and a beta of 1.36. The stock has a 50 day moving average of $481.73 and a 200-day moving average of $446.85. HCA Healthcare, Inc. has a 52 week low of $295.00 and a 52 week high of $552.90.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping the consensus estimate of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company had revenue of $19.51 billion during the quarter, compared to analyst estimates of $19.67 billion. During the same period last year, the business earned $6.22 EPS. The firm’s revenue for the quarter was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be given a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s payout ratio is 10.15%.

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 8,020 shares of the business’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the sale, the senior vice president owned 11,993 shares of the company’s stock, valued at $6,171,357.94. This represents a 40.07% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total value of $2,020,000.00. Following the completion of the transaction, the senior vice president owned 44,379 shares of the company’s stock, valued at approximately $22,411,395. The trade was a 8.27% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 13,520 shares of company stock valued at $6,894,067. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.